Pregnancies affected by cardiovascular disease (CVD) are rising due to older maternal age, survival of women with congenital heart disease reaching childbearing age, and increasing cardiovascular comorbidities. CVD is now the leading cause of non-obstetric maternal death worldwide, posing significant maternal, neonatal, and long-term risks.
This month, FOCUS delves into the 2025 ESC Guidelines on Cardiovascular Disease and Pregnancy, which introduced significant updates, including dedicated chapters on the Pregnancy Heart Team, a revised risk-stratification framework, expanded disease-specific management strategies, illustrative clinical scenarios, and new insights into the long-term impact of adverse pregnancy outcomes.
The content below was selected by Ronen Beeri, Maria Generosa Crespo Leiro, Julie De Backer and Kristina Hermann Haugaa to help you delve into the various aspects of risk scores in cardiovascular disease during pregnancy.
Webinars
The Pregnancy Heart Team unveiled in the 2025 ESC Guidelines: who is in, who benefits, and how to deliver
17 September 2025
With Julie De Backer, Michèle de Hosson and Lorna Swan
2025 ESC Guidelines on Cardiovascular Disease and Pregnancy: management of heart failure and arrhythmias
24 September 2025
With Nina Hasselberg, Kristina Haugaa and Amina Rakisheva


Our mission: To reduce the burden of cardiovascular disease.